{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Makers Laboratories Ltd
Are Makers Laboratories Ltd latest results good or bad?
Makers Laboratories Ltd's latest Q3 FY26 results show strong sales growth of 28.82% year-on-year, but a significant decline in net profit of 84.86% compared to the previous year raises concerns about long-term sustainability and investor confidence. While operational performance has improved, challenges remain evident in profitability and capital efficiency.
Makers Laboratories Q3 FY26: Profit Surge Masks Deeper Structural Concerns
Makers Laboratories Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹85.56 crores, reported a consolidated net profit of ₹0.94 crores for Q3 FY26 (October-December 2025), marking a dramatic turnaround from a loss of ₹0.30 crores in the year-ago quarter. However, the seemingly impressive quarterly performance conceals troubling underlying trends that raise serious questions about the sustainability of this recovery.
Makers Laboratories Ltd is Rated Strong Sell
Makers Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Makers Laboratories Ltd is Rated Strong Sell
Makers Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 September 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Makers Laboratories Ltd is Rated Strong Sell
Makers Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Why is Makers Laboratories Ltd falling/rising?
On 16-Jan, Makers Laboratories Ltd saw its share price rise by 3.5% to ₹124.30, continuing a three-day winning streak that has delivered a 7.57% gain over this short period. This recent uptick contrasts with the stock’s longer-term underperformance and reflects a complex interplay of short-term market dynamics and persistent fundamental weaknesses.
Makers Laboratories Ltd is Rated Strong Sell
Makers Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 07 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Makers Laboratories Ltd is Rated Strong Sell
Makers Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 September 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into the company’s performance and outlook.
Makers Laboratories Stock Falls to 52-Week Low of Rs.109 Amidst Prolonged Underperformance
Makers Laboratories has reached a new 52-week low of Rs.109, marking a significant decline in its stock price amid a year characterised by subdued financial performance and persistent volatility. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing challenges in maintaining growth momentum.
Makers Labs. Sees Revision in Market Evaluation Amidst Challenging Financial Trends
Makers Labs., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. This shift highlights the company's current position within a competitive and volatile industry landscape.
Makers Laboratories Stock Falls to 52-Week Low of Rs.114.95
Makers Laboratories has reached a new 52-week low, with its share price touching Rs.114.95 today. This marks a significant decline for the pharmaceutical company amid broader market fluctuations and sector-specific pressures.
Why is Makers Labs. falling/rising?
As of 13-Nov, Makers Laboratories Ltd is currently priced at Rs 132.70, reflecting a 7.75% increase. Despite recent gains, the stock's year-to-date performance is negative at -26.71%, and it has underperformed over the past year compared to the benchmark.
Makers Laboratories Stock Plummets to New 52-Week Low at Rs. 117.95
Makers Laboratories has hit a new 52-week low, reflecting a notable decline in its stock performance. The company has underperformed its sector and experienced a consecutive drop over three days. Its long-term fundamentals show weakness, with decreased operating profits and low return on equity.
Makers Laboratories Stock Plummets to New 52-Week Low at Rs. 117.95
Makers Laboratories has reached a new 52-week low of Rs. 117.95, marking a significant downturn for the stock, which has underperformed its sector. The stock has declined over the past three days and is trading below multiple moving averages, reflecting a sustained downward trend amid broader market fluctuations.
Makers Laboratories Stock Plummets to New 52-Week Low at Rs. 117.95
Makers Laboratories has reached a new 52-week low, reflecting a significant decline in its stock performance. The stock has underperformed its sector and has seen a consecutive drop over three days. It is currently trading below multiple moving averages, indicating a persistent downward trend amid broader market volatility.
Is Makers Labs. overvalued or undervalued?
As of November 10, 2025, Makers Labs. is considered overvalued with a PE ratio of -4693.22, unfavorable comparisons to peers like Sun Pharma and Cipla, and a significant year-to-date stock decline of 34% versus the Sensex's gain of 6.91%.
Why is Makers Labs. falling/rising?
As of 10-Nov, Makers Laboratories Ltd's stock price is Rs 119.50, down 5.16%, and has underperformed significantly compared to the Sensex, with a year-to-date decline of 34.00%. The stock is near its 52-week low and trading below all major moving averages, indicating a bearish trend and reduced investor participation.
How has been the historical performance of Makers Labs.?
Makers Labs has shown fluctuating performance over the past five years, with net sales increasing to 120.75 Cr in March 2025, and a significant recovery in profitability, reporting a profit after tax of 10.91 Cr. However, the company faces challenges with negative cash flow of -4.00 Cr in March 2025.
Are Makers Labs. latest results good or bad?
Makers Laboratories' latest Q2 FY26 results show a net loss of ₹0.12 crores despite a year-on-year sales growth of 15.56%, indicating operational challenges and declining margins. While the return on equity improved, the company faces significant issues with cash flow and overall financial health.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
